Bryant David Lim, SVP & GC at Aceragen, holds 2.40K shares in Prelude Therapeutics (Ticker: PRLD), holds 309.69K shares in Aceragen (Ticker: ACGN). Most recently, Bryant David Lim Bought ― shares of Prelude Therapeutics on May 25, 2023 for an estimated value of 12.94K.